Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06915610Enrolling by invitation
New cervical cancer screening program study
This study is testing a new way to organize cervical cancer screening in Portugal using modern tools. It may help make screening more convenient and up-to-date for women who qualify.
Vila Nova de GaiaAges 30–69 - NCT07790770RecruitingPhase 1
A study of a new drug in healthy adults
This study tests a new drug called CMS-F021 in healthy volunteers. It aims to see how the drug behaves in the body after single and multiple doses.
BeijingAges 18–55 - NCT07757152RecruitingPhase 1
Study of ZL-65 tablet in healthy adults
This trial tests a new medicine called ZL-65, which may help treat certain conditions by reducing inflammation. It is a first-in-human study to see if the drug is safe and how the body handles it.
Chengdu, SichuanAges 18–45 - NCT07694843RecruitingPhase 1
Study of ammoxetine for people with mild to moderate liver problems
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
Suzhou, JiangsuAges 18–75 - NCT06643468Enrolling by invitation
ALB-PRF with bone grafts for immediate dental implants
This trial tests whether using a special protein-rich blood product (ALB-PRF) with two different types of putty-like bone grafts helps improve the success of dental implants placed right after a tooth is removed in the front upper jaw. It may help people who need a tooth replaced in the 'smile zone' and have good oral health.
Al MansurahAges 20–60 - NCT06576271RecruitingPhase 1
Testing a new drug for lupus and related lung disease
This study tests an experimental drug called GSK4527363. It is first being given to healthy volunteers to check safety, then to people with lupus (SLE) and people with connective tissue disease-related lung disease (CTD-ILD). The goal is to see if the drug is safe and how the body processes it.
Scottsdale, ArizonaAges 18–65 - NCT06349473RecruitingPhase 1
Study of SR604 in healthy people and those with bleeding disorders
This study tests a new drug called SR604 to see if it is safe and how it works in the body. It is for healthy men and for people with hemophilia A, hemophilia B, or factor VII deficiency who have frequent bleeding or are on preventive treatment.
Glendale, CaliforniaAges 18–60 - NCT06003634Recruiting
Peer Support for Type 2 Diabetes in Rural Kentucky
This study tests whether having a trained peer coach (a person who also has diabetes) can help older adults in rural Kentucky better manage their Type 2 Diabetes. If you join, you'll get support from someone who understands your experience.
Bowling Green, KentuckyAges 55 years+ - NCT07793019RecruitingPhase 1
Weight loss and safety study in overweight adults
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Beijing, Beijing MunicipalityAges 18–55 - NCT07758595RecruitingPhase 1
Study of DNL921 for healthy people and people with Alzheimer's disease
This trial tests an investigational drug called DNL921 in healthy volunteers and in people with mild to moderate Alzheimer's disease. The goal is to see if it is safe and how the body handles it, which is a first step in finding a new treatment.
ManchesterAges 18–75 - NCT07751250RecruitingPhase 1
Casdatifan in moderate liver impairment
This study looks at how a new drug, casdatifan, is processed in the body in people with moderate liver problems compared to healthy people. Understanding this helps doctors decide if the drug is safe and how to dose it for patients with liver issues.
San Antonio, TexasAges 18–84 - NCT07694869RecruitingPhase 1
Study of ammoxetine tablets in people with moderate kidney problems
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
Hefei, AnhuiAges 18–75 - NCT07578584RecruitingPhase 1
Safety study of NNC0497-0040 in healthy and overweight adults
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
NeussAges 18–55 - NCT07559253Recruiting
Heart Care Transition Education Led by Nurses or Doctors
This study tests whether nurse-led or doctor-led education helps young people with congenital heart disease (a heart condition present from birth) transition from pediatric to adult care. The goal is to make this transition smoother and more accessible for all patients, including those with disabilities.
Madison, WisconsinAges 12–26 - NCT07463196RecruitingPhase 1
Study of ACI-19764 for healthy people and those with heart risks
This trial tests an experimental drug called ACI-19764 to see how safe it is, how the body handles it, and how it affects the immune system. It's for healthy adults and for adults with heart-related risk factors like obesity or type 2 diabetes.
GroningenAges 18–75 - NCT07344948RecruitingEarly Phase 1
Testing NTX-253 in healthy people and those with stable schizophrenia
This trial is testing a new medicine, NTX-253, to see how safe it is and how the body processes it. It is for healthy adults and adults with schizophrenia whose symptoms are stable on their current treatment.
Los Alamitos, CaliforniaAges 18–55 - NCT07047703RecruitingPhase 1/Phase 2
Study of an investigational drug for axial spondyloarthritis
This trial tests a new oral medication that may reduce inflammation and improve symptoms in people with axial spondyloarthritis. It is in early phases, meaning the drug is still being studied for safety and effectiveness.
BirtinyaAges 18–65 - NCT06980428RecruitingPhase 1
Safety study of AZD4954 in people with or without high Lp(a)
This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.
Glendale, CaliforniaAges 18–70 - NCT06562907RecruitingPhase 1
Study of an experimental drug for weight and diabetes
This study tests an investigational drug called GS-4571 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects the body and whether it might help with weight and blood sugar control.
Miami, FloridaAges 18–65 - NCT05945355Recruiting
Study of breathing training for children with asthma
This study looks at how an asthma-specific breathing training program affects children’s breathing and asthma control. It may help your care team understand who could benefit from inspiratory (breathing-in) training.
Durham, North CarolinaAges 6–17 - NCT05390567Recruiting
Mobile reminders to help women catch up on cancer screening
This study tests a mobile outreach effort to help women who are behind on recommended cervical cancer screening. It may help you learn when to get screened and connect you to care that may be easier to access.
Gainesville, FloridaAges 25–65 - NCT07879170RecruitingPhase 1
Testing a new epilepsy medicine in healthy adults
This study tests a new medicine, EPX-100, for epilepsy in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
Tempe, ArizonaAges 18–55 - NCT07093580RecruitingPhase 1
Study of a long-acting injectable in healthy adults
This study tests a new long-acting injectable medication (S-892216 LAI) in healthy adults. It helps researchers understand how the drug works in the body when given as a shot, which could lead to a treatment given less often in the future.
Cypress, CaliforniaAges 18–55 - NCT07658560RecruitingPhase 2
Weight loss pill study for overweight or obese adults without diabetes
This study tests an experimental pill, BGM0504, to see if it helps overweight or obese adults lose weight safely. Participants will take the pill while continuing their usual diet and exercise routine.
Beijing, Beijing MunicipalityAges 18–55
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.